From the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Ebacin is a financial institution. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €398,037 and a net result of €330,474. Equity has been growing by about 55% per year since 2023. Its solvency ranks better than 64% of 6,687 sector peers (NACE 64, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
08-03
Gazette deed
Appointment: Destracon BV (gedelegeerdbestuurder)Permanent representative: Rudolphe Brackman3 points ▸
- Board meeting, 16-01-2023
- Director appointment, Destracon BV (gedelegeerdbestuurder)
- Permanent representative, Rudolphe Brackman (vastevertegenwoordiger)
11-01
Gazette deed
IncorporationAppointments: KLACKEN (director) and Destracon (director) · Permanent representatives: Grawet Lieve Maria Paul and BRACKMAN Rudolphe · Founder16 points ▸
- Founder, KLACKEN
- Founder, Destracon
- Incorporation, “Ebacin” (deed in Dutch)
- Founding capital, €100,000
- Bank account, “BE70 7340 6587 4325”, EUR (deed in Dutch)
- Other provision, 08-12-2022
- Other provision, “hoofdelijke aansprakelijkheid oprichters bij faillissement, faillissement uitgesproken binnen drie jaar na verkrijging rechtspersoonlijkheid indien aanvangsverm…” (deed in Dutch)
- Capital, €100,000
- Registered office clause, “9820 Merelbeke,Industriepark 13, neerlegging ter griffie van uittreksel oprichtingsakte” (deed in Dutch)
- Board rule, 2, “aantal bestuurders vastgesteld” (deed in Dutch)
- Director appointment, KLACKEN (director)
- Director appointment, Destracon (director)
- The act holds 4 more points.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank